中华消化内镜杂志
中華消化內鏡雜誌
중화소화내경잡지
CHINESE JOURNAL OF DIGESTIVE ENDOSCOPY
2009年
5期
253-255
,共3页
韩树堂%史伟%张小琴%张以洋%张其德%肖君%周玉宏%胡余美%姜素峰
韓樹堂%史偉%張小琴%張以洋%張其德%肖君%週玉宏%鬍餘美%薑素峰
한수당%사위%장소금%장이양%장기덕%초군%주옥굉%호여미%강소봉
胆道肿瘤%恶性梗阻%胆管%胰腺管%支架
膽道腫瘤%噁性梗阻%膽管%胰腺管%支架
담도종류%악성경조%담관%이선관%지가
Biliary tract neoplasms%Malignant obstruction%Bile ducts%Pancreatic ducts%Stents
目的 探讨晚期壶腹周围癌患者胆管和胰管双支架治疗的临床价值.方法 36例经病理学和(或)临床诊断为晚期壶腹周围癌患者,影像学表现为胰管和胆管均有狭窄,经内镜先在胰管内置入Teflon塑料支架,然后胆道内置入可膨胀式金属支架,不成功者改经皮经肝胆管内置入金属支架进行引流.观察支架置放前后患者的血清肝生化指标、胰酶水平和临床表现.结果 36例置入胰管塑料支架均顺利,29例内镜置入金属胆道支架成功,7例(2例Billroth Ⅱ术后)因导丝插入胆管困难改为经皮经肝胆管内支架置入.支架置放后肝ALT、AST、ALP、r-谷氨酰转肽酶以及总胆红素、直接胆红素均有明显的下降;15例出现血淀粉酶和血脂肪酶的升高,但经过治疗后均恢复正常;腹痛缓解率82.4%(28/34),腹泻改善有效率达88.2%(15/17).结论 胆、胰管联合支架可以解除壶腹周围癌患者的胆、胰管恶性狭窄与梗阻,安全有效.
目的 探討晚期壺腹週圍癌患者膽管和胰管雙支架治療的臨床價值.方法 36例經病理學和(或)臨床診斷為晚期壺腹週圍癌患者,影像學錶現為胰管和膽管均有狹窄,經內鏡先在胰管內置入Teflon塑料支架,然後膽道內置入可膨脹式金屬支架,不成功者改經皮經肝膽管內置入金屬支架進行引流.觀察支架置放前後患者的血清肝生化指標、胰酶水平和臨床錶現.結果 36例置入胰管塑料支架均順利,29例內鏡置入金屬膽道支架成功,7例(2例Billroth Ⅱ術後)因導絲插入膽管睏難改為經皮經肝膽管內支架置入.支架置放後肝ALT、AST、ALP、r-穀氨酰轉肽酶以及總膽紅素、直接膽紅素均有明顯的下降;15例齣現血澱粉酶和血脂肪酶的升高,但經過治療後均恢複正常;腹痛緩解率82.4%(28/34),腹瀉改善有效率達88.2%(15/17).結論 膽、胰管聯閤支架可以解除壺腹週圍癌患者的膽、胰管噁性狹窄與梗阻,安全有效.
목적 탐토만기호복주위암환자담관화이관쌍지가치료적림상개치.방법 36례경병이학화(혹)림상진단위만기호복주위암환자,영상학표현위이관화담관균유협착,경내경선재이관내치입Teflon소료지가,연후담도내치입가팽창식금속지가,불성공자개경피경간담관내치입금속지가진행인류.관찰지가치방전후환자적혈청간생화지표、이매수평화림상표현.결과 36례치입이관소료지가균순리,29례내경치입금속담도지가성공,7례(2례Billroth Ⅱ술후)인도사삽입담관곤난개위경피경간담관내지가치입.지가치방후간ALT、AST、ALP、r-곡안선전태매이급총담홍소、직접담홍소균유명현적하강;15례출현혈정분매화혈지방매적승고,단경과치료후균회복정상;복통완해솔82.4%(28/34),복사개선유효솔체88.2%(15/17).결론 담、이관연합지가가이해제호복주위암환자적담、이관악성협착여경조,안전유효.
Objective To evaluate the efficacy of biliary tract prosthesis and pancreatic duct stents for advanced periampullary carcinoma. Methods A total of 36 patients were diagnosed as advanced periampullary carcinoma pathologically or clinically, with strictures both in pancreatic and biliary ducts confirmed by imaging. Teflon stents were firstly implanted through endoscopy to the narrowed pancreatic ducts, expansible metal prosthesis were then implanted to the biliary tract. If failed, the metal stents were given through percutaneous transhepatic biliary drainage (PTCD) pathway. Serum levels of liver enzymes, amylase and clinical manifestations were observed before and after operation. Results Teflon stents were successfully implanted into pancreatic ducts in all patients. Metal prostheses into bile ducts were endoscopically implanted in 29 cases, and via PTCD in 7, including 2 cases of Billroth Ⅱ gastrectomy. The levels of liver enzymes significantly decreased (P<0.01) after stents implacement. The levels of amylase (plasma and urine) and lipase increased in 15 cases, but they were corrected to normal levels after adequate treatments. Rates of abdominal pain relieving and diahhrea improvement were 82.4% (28/34) and 88.2% (15/17), respectively. Conclusion The combined implacement of biliary tract prosthesis and pancreatic duct stents is safe and effective in relieving malignant obstruction in periampullary carcinoma.